RxDoctor Payments DataLook up a doctor →

John Brandsema

Neurology with Special Qualifications in Child Neurology · Philadelphia, PANPI 1275889792

Payments from drug & device makers

$4,453,106in general payments, 2019–2025

Across 1,141 payments — averaging $3902.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sarepta Therapeutics, Inc.$1.7M
  • Biogen$1.1M
  • Pfizer$740K
  • AstraZeneca$305K
  • UCB SA$89K
  • Novartis$86K
  • plus $479K from 17 others
$16,857in research payments, 2019–2025

Across 12 payments — averaging $1404.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$8K
  • Biogen$7K
  • Sarepta Therapeutics, Inc.$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,453,106 in reported general payments places this provider in the 95th percentile of 83 neurology with special qualifications in child neurology providers in Pennsylvania.

See all neurology with special qualifications in child neurology providers in Pennsylvania

Other neurology with special qualifications in child neurology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →